Smith+Nephew Unveils New Chronic Wound Care Technologies
BREMEN, Germany, May 5, 2026 Smith+Nephew, the global medical technology company specializing in advanced wound management and surgical innovation,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BREMEN, Germany, May 5, 2026 Smith+Nephew, the global medical technology company specializing in advanced wound management and surgical innovation,...
SANTA CLARA, Calif., United States – May 5, 2026 Johnson & Johnson has announced pivotal clinical study results for...
BOSTON, April 24, 2026 Haemonetics Corporation has announced compelling new clinical data demonstrating the safety, efficacy, and superior performance...
LONDON, April 23, 2026 In a significant advancement for vascular access treatment, FLEX Vascular has announced 12-month real-world outcomes...
LOS GATOS, Calif., April 13, 2026 Radical Catheter Technologies has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
BALTIMORE, MARYLAND, USA, April 13, 2026 Protaryx Medical has received U.S. FDA 510(k) clearance for its Transseptal Puncture Device,...
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
MOUNTAIN VIEW, Calif., April 07, 2026 AliveCor Inc., a global leader in AI-powered cardiology solutions, has announced the regulatory...
IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSEâ„¢ Pro, an...
ATLANTA, Georgia, United States, April 7, 2026 Artivion, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
